Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1984-2-20
pubmed:abstractText
Different azidocalmodulin derivatives were synthesized by modification of either one carboxylic acid group or one or several arginine residues and their binding and activation capacity investigated in three target enzyme systems. The systems studied were smooth-muscle myosin light-chain kinase, cardiac sarcoplasmic-reticulum kinase and erythrocyte (Mg2+ + Ca2+)-dependent ATPase. The results indicated that the activation ability of each calmodulin derivative was different depending on the system studied. Binding studies carried out by the displacement of 125I-calmodulin indicated that the monosubstitutions did not greatly alter the apparent Kd of calmodulin for the enzymes but that the modification of four arginine residues caused a 4-8-fold increase in the apparent Kd in all systems. These results have shown that azidocalmodulin derivatives may have different degrees of usefulness in the study of calmodulin target proteins in different systems, with the behaviour of the derivatives not predictable on the basis of the nature (soluble or membrane-bound) or the type (ATPase or kinase) of enzyme system to be investigated. However, the monosubstituted calmodulin and, in particular, the carboxylic acid-group-modified derivative (where the modification was statistically dispersed over the protein chain) are good candidates for photolabelling calmodulin-binding proteins.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/6140918-1054843, http://linkedlifedata.com/resource/pubmed/commentcorrection/6140918-124591, http://linkedlifedata.com/resource/pubmed/commentcorrection/6140918-180019, http://linkedlifedata.com/resource/pubmed/commentcorrection/6140918-197956, http://linkedlifedata.com/resource/pubmed/commentcorrection/6140918-207336, http://linkedlifedata.com/resource/pubmed/commentcorrection/6140918-227448, http://linkedlifedata.com/resource/pubmed/commentcorrection/6140918-227880, http://linkedlifedata.com/resource/pubmed/commentcorrection/6140918-234432, http://linkedlifedata.com/resource/pubmed/commentcorrection/6140918-24446, http://linkedlifedata.com/resource/pubmed/commentcorrection/6140918-4117794, http://linkedlifedata.com/resource/pubmed/commentcorrection/6140918-4230833, http://linkedlifedata.com/resource/pubmed/commentcorrection/6140918-4375761, http://linkedlifedata.com/resource/pubmed/commentcorrection/6140918-5832284, http://linkedlifedata.com/resource/pubmed/commentcorrection/6140918-6114951, http://linkedlifedata.com/resource/pubmed/commentcorrection/6140918-6210437, http://linkedlifedata.com/resource/pubmed/commentcorrection/6140918-6244945, http://linkedlifedata.com/resource/pubmed/commentcorrection/6140918-6250447, http://linkedlifedata.com/resource/pubmed/commentcorrection/6140918-6265467, http://linkedlifedata.com/resource/pubmed/commentcorrection/6140918-6265911, http://linkedlifedata.com/resource/pubmed/commentcorrection/6140918-6444295, http://linkedlifedata.com/resource/pubmed/commentcorrection/6140918-655375, http://linkedlifedata.com/resource/pubmed/commentcorrection/6140918-6762067, http://linkedlifedata.com/resource/pubmed/commentcorrection/6140918-6832360, http://linkedlifedata.com/resource/pubmed/commentcorrection/6140918-6894553, http://linkedlifedata.com/resource/pubmed/commentcorrection/6140918-7026566, http://linkedlifedata.com/resource/pubmed/commentcorrection/6140918-7202416, http://linkedlifedata.com/resource/pubmed/commentcorrection/6140918-7316186, http://linkedlifedata.com/resource/pubmed/commentcorrection/6140918-7397242, http://linkedlifedata.com/resource/pubmed/commentcorrection/6140918-762156
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0264-6021
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
215
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
475-82
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:6140918-Amino Acids, pubmed-meshheading:6140918-Animals, pubmed-meshheading:6140918-Azides, pubmed-meshheading:6140918-Ca(2+) Mg(2+)-ATPase, pubmed-meshheading:6140918-Calcium-Transporting ATPases, pubmed-meshheading:6140918-Calmodulin, pubmed-meshheading:6140918-Cattle, pubmed-meshheading:6140918-Chromatography, High Pressure Liquid, pubmed-meshheading:6140918-Dogs, pubmed-meshheading:6140918-Electrophoresis, Cellulose Acetate, pubmed-meshheading:6140918-Enzyme Activation, pubmed-meshheading:6140918-Humans, pubmed-meshheading:6140918-Kinetics, pubmed-meshheading:6140918-Myosin-Light-Chain Kinase, pubmed-meshheading:6140918-Peptide Fragments, pubmed-meshheading:6140918-Protein Binding, pubmed-meshheading:6140918-Protein Kinases, pubmed-meshheading:6140918-Sarcoplasmic Reticulum
pubmed:year
1983
pubmed:articleTitle
Azidocalmodulin derivatives. Activation of, and binding to, three target proteins: aorta myosin light-chain kinase, erythrocyte (Mg2+ + Ca2+)-dependent ATPase and cardiac sarcoplasmic-reticulum kinase.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't